Integra LifeSciences announced that it completed its previously announced acquisition of Acclarent from Johnson & Johnson MedTech . Princeton, New Jersey-based Integra struck a deal with J&J to acquire Acclarent for $275 million upfront at the end of 2023. The deal also includes an additional $5 million upon the achievement of regulatory milestones. Acclarent, part […]
Featured
Onward submits movement-restoring spinal cord stim tech to FDA
Onward Medical announced today that it submitted a de novo application to the FDA for the approval of its ARC-EX spinal cord stimulation system. The Eindhoven, the Netherlands-based company designed ARC-EX to restore function of upper extremities after spinal cord injury (SCI). If approved, the company says ARC-EX would become the first ever SCS therapy […]
Politan picks a new Masimo board fight, targeting CEO’s seat after recent wins
Masimo is fighting with Politan Capital Management again after the activist investor won a heated battle for two seats last year. Politan Managing Partner and Chief Investment Officer Quentin Koffey said his firm is nominating two more candidates for election to the board at this year’s annual meeting in a bid to take control of […]
FDA clears Baxter Novum IQ large-volume infusion pump, Dose IQ safety software
Baxter (NYSE:BAX) announced today that the FDA granted 510(k) clearance for its Novum IQ large-volume infusion pump (LVP) with Dose IQ safety software. Clearance adds the LVP to the Novum IQ platform, which already includes the Baxter syringe infusion pump (SYR). It enables clinicians to utilize a single, integrated system across a variety of patient […]
ZimVie closes sale of spine business, medtech veterans make up leadership team
ZimVie announced today that it completed the sale of its spine business to establish itself as a pure-play dental company. The company also shared details on the makeup of the leadership team at the now-sold business unit. The Westminster, Colorado-based ZimVie announced its intent to sell the spine business to H.I.G. Capital in December 2023. […]
3M completes Solventum healthcare business spinoff
3M announced today that it completed the spinoff of its Solventum healthcare business as a standalone company. Following the completion of the spinoff, Solventum is now listed on the New York Stock Exchange under the “SOLV” ticker. The 3M board approved the spinoff in March, confirming the effective date for today, April 1. The St. […]
President of Medtronic Gastrointestinal is leaving, replacement named
Gio Di Napoli, president of the Gastrointestinal business at Medtronic , announced today that he is departing his post at the medtech giant. His leaving marks the second departure of a business unit president at Medtronic this month. Ariel Mactavish, president of the company’s Respiratory Interventions unit, also announced that she was leaving the company. […]
Hologic to shutter some facilities within diagnostics unit
Hologic plans to close certain international facilities amid product discontinuations and restructuring within its diagnostics business. The company outlined the changes — first reported by MedTech Dive — in its quarterly Form 10-Q filed with the SEC, dated Feb. 2, 2024. Hologic reported accelerated depreciation of $7.2 million and a lease asset impairment charge totaling […]
JenaValve publishes positive data for its TAVR system
JenaValve announced today that it published new results supporting the use of its transcatheter aortic valve replacement (TAVR) system. The company published results from its ALIGN-AR pivotal trial in The Lancet. The trial evaluates the Trilogy valve in high-risk patients with symptomatic moderate-to-severe or severe aortic regurgitation. JenaValve presented positive study results from ALIGN-AR last […]
Tandem Diabetes Care taps miniaturization and automation for its latest systems
Tandem Diabetes Care (Nasdaq:TNDM) EVP and Chief Strategy Officer Elizabeth Gasser didn’t exactly plan for the whirlwind past year or so. In the space of about two months, Tandem announced continuous glucose monitor (CGM) integration with the latest-generation technology from Dexcom and Abbott, launched its Tandem Source diabetes management platform and began the rollout of […]
Neuralink may be getting some scrutiny on Capitol Hill
Reuters reports that U.S. Rep. Earl Blumenauer (D-OR) issued a letter to the FDA questioning its inspection practices related to Neuralink. The report said Blumenauer asked why the FDA decided not to investigate the Elon Musk-backed brain chip maker before allowing in-human trials. This relates to repeated questions around animal practices at the company. Reuters […]